Fig 1.
Annual incidence (per million population) of reported anaplasmosis and ehrlichiosis in the United States for 2022 (adapted from [8,9], materials developed by CDC).
Fig 2.
Epidemiological distribution of the analyzed 176 HGA and 272 HME cases according to age, sex, and immune status using US data.
Table 1.
Comparison of the demographic data of the analyzed 176 HGA and 272 HME cases.
Table 2.
Comparison of the symptoms and signs of the analyzed 176 HGA and 272 HME cases.
Table 3.
Comparison of the laboratory parameters of the analyzed 176 HGA and 272 HME cases.
Table 4.
Comparison of hospitalization rate, occurrence of complication(s) and outcome of the analyzed 176 HGA and 272 HME cases.